These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3053069)

  • 21. Indications for HLA typing in granulocyte and platelet concentrate transfusions.
    McCredie KB
    Prog Clin Biol Res; 1981; 65():101-7. PubMed ID: 7330067
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood and blood transfusion reactions: 2.
    Bradbury M; Cruickshank JP
    Br J Nurs; 1995 Aug 10-Sep 13; 4(15):861-8. PubMed ID: 7655286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfusion reactions. Their recognition and management.
    Maxwell I
    N S Med Bull; 1973 Aug; 52(4):164-5. PubMed ID: 4517281
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of HLA antibody synthesis due to blood transfusion in 314 patients from the Isfahan (Iran) Transplantation Center.
    Adib M; Abkar Shahnazar E
    Transplant Proc; 2000 May; 32(3):598. PubMed ID: 10812130
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation.
    Adorno D; Valeri M; Piazza A; Bonini S; Papola F; Casciani CU
    Transplant Proc; 1979 Jun; 11(2):1269-70. PubMed ID: 382505
    [No Abstract]   [Full Text] [Related]  

  • 26. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral immunomodulatory effect of influenza vaccine in potential blood donors: implications for transfusion safety.
    Delaney M; Warner P; Nelson K; Gleckler C; Price T; Madeleine M
    Transfus Med; 2011 Dec; 21(6):378-84. PubMed ID: 21883543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reactions.
    Brubaker DB
    Transfusion; 1990 Oct; 30(8):733-7. PubMed ID: 2219262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion-related acute lung injury resulting from designated blood transfusion between mother and child: a report of two cases.
    Yang X; Ahmed S; Chandrasekaran V
    Am J Clin Pathol; 2004 Apr; 121(4):590-2. PubMed ID: 15080312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Attempted clearance by massive plasmapheresis of an anti-HLA antibody in a patient who had received multiple transfusions (author's transl)].
    Sebahoun G; Lefevre P; Carcassonne Y; Battaglini P
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2483. PubMed ID: 693295
    [No Abstract]   [Full Text] [Related]  

  • 31. Positive irregular antibody screen due to leukocyte antibody.
    Larsen AE; McIntyre CR
    Am J Med Technol; 1975 Jul; 41(7):259-61. PubMed ID: 1163555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
    Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
    Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risks in transfusion therapy].
    Schricker KT
    Klin Anasthesiol Intensivther; 1980; 21():106-19. PubMed ID: 6779051
    [No Abstract]   [Full Text] [Related]  

  • 34. Death due to blood transfusion-induced anaphylactic shock: A case report.
    Nara A; Aki T; Funakoshi T; Uchida K; Nakayama H; Uemura K
    Leg Med (Tokyo); 2010 May; 12(3):148-50. PubMed ID: 20303818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte reduction reduces the rate of febrile nonhemolytic transfusion reactions to platelets and red blood cells.
    Blackall DP
    Curr Hematol Rep; 2004 Nov; 3(6):435-6. PubMed ID: 15496277
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonhemolytic transfusion reactions: reducing the incidence with leukocyte-poor red blood cells.
    Lichtiger B; Osier LE
    South Med J; 1983 Mar; 76(3):419. PubMed ID: 6828921
    [No Abstract]   [Full Text] [Related]  

  • 37. [Strategies for prevention of adverse transfusion effects. Immediate and delayed transfusion effects: laboratory reference for transfusion reactions].
    Kiyokawa H
    Rinsho Byori; 1991 Mar; Suppl 88():128-37. PubMed ID: 1856964
    [No Abstract]   [Full Text] [Related]  

  • 38. [One-way matching of HLA antigens between recipient and donor as a risk factor of transfusion-associated GVHD].
    Takahashi K
    Nihon Rinsho; 1997 Sep; 55(9):2240-5. PubMed ID: 9301283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor risk factors for white blood cell antibodies associated with transfusion-associated acute lung injury: REDS-II leukocyte antibody prevalence study (LAPS).
    Triulzi DJ; Kakaiya R; Schreiber G
    Transfusion; 2007 Apr; 47(4):563-4. PubMed ID: 17381611
    [No Abstract]   [Full Text] [Related]  

  • 40. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE; Duquesnoy RJ
    Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.